Consumer Analyst Group of New York Conference (CAGNY) 2026
Logotype for Reckitt Benckiser Group plc

Reckitt Benckiser Group (RKT) Consumer Analyst Group of New York Conference (CAGNY) 2026 summary

Event summary combining transcript, slides, and related documents.

Logotype for Reckitt Benckiser Group plc

Consumer Analyst Group of New York Conference (CAGNY) 2026 summary

7 Apr, 2026

Strategic transformation and portfolio focus

  • Sharpened portfolio by divesting non-core segments and simplifying operations, focusing on 11 Powerbrands that contribute 80% of core net revenue in FY24.

  • Mead Johnson remains under review for future options, further streamlining the business.

  • Emphasis on a simpler, sharper operating model to drive executional excellence and sustainable momentum.

  • Reduced management layers and executive roles, increasing accountability and cost efficiency.

  • Strategic plan delivered through restructuring, focus, and execution over the past 18 months, including divestment of non-core assets in 2025.

Growth drivers and market opportunities

  • Emerging markets now surpass North America and Europe in $25K+ households, reaching 316m in 2024 and providing a major growth runway.

  • High growth runways identified in self care, germ protection, household care, and intimate wellness, with significant underpenetration in several categories.

  • Focus on expanding category penetration and premiumization, especially in emerging markets and through innovation.

  • Ambition to achieve 4%-5% like-for-like growth, with emerging markets already delivering 14% top-line growth in 2025.

  • Premium brand positioning enables high gross margins and reinvestment in innovation and marketing.

Brand strength and innovation

  • Iconic Powerbrands like Dettol, Lysol, Finish, Durex, and Mucinex lead their categories globally, supported by innovation and consumer trust.

  • Dettol is used over a billion times a year and is the #1 trusted brand in multiple countries.

  • AI-driven tools accelerate concept generation and innovation, reducing time-to-market and improving success rates.

  • Notable product launches include Durex Intensity and a new 12-hour cold and flu relief product set for 2026.

  • Durex drives market leadership and premiumisation through material science innovation, including non-latex and hyaluronic acid condoms.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more